Brief Introduction

Founded in the scenic Science City, Guangzhou, in 2001, Guangzhou JET Bio-Filtration Co., Ltd. covers an area of 22,468 square meters and is a well-known company in China involving R&D, manufacturing and sales of laboratory consumable products. Up to now we have developed 34 series, totally 350 kinds of products. JET is well known for its broad variety of different kinds of products, such as Tissue culture plates, flasks and dishes, vacuum and syringe driven filters, serological and aspirating pipets, centrifuge tubes and much more, giving our customer one stop shop privilege. Our products are mainly exported (>80%) to oversea, such as USA, UK, Canada, Germany, Australia, Israel, Russia, India, Japan, Korea and so on. Our plastic injection, extrusion, blow molding, plastic stretching, silk-printing, assembling and packaging were operated in a total area of 12,000 square meters of 100,000 grade clean-room facility under EN ISO 13485, ISO 9001 and CE quality management system; this allow us to meet the requirement of DNase/RNase Free and Non-pyrogenic specialties. In addition, a QA/QC system guarantees the quality of products to the international standard.

Since its establishment, the company has been committed to the research, development, production and sales of disposable plastic consumables in biological laboratories. With many years of research and practice on industry technology development trends, it has applied a number of polymer material modification and manufacturing process improvements and other technologies to Biological laboratory disposable plastic consumables have accumulated rich experience in R&D, manufacturing and operation, and have established relative leading advantages in the domestic industry, including technological innovation advantages, relatively advanced process equipment system and efficient industrialization capability, production process with independent intellectual property rights through technological innovation, quality control advantages, cost advantage and superior customer resource advantages.

JET has formed a very professional R&D team. JET's R&D team size and capabilities are in a relatively leading position among domestic counterparts. JET has formed an advanced in key links such as extrusion molding process, automatic stretching process, cutting process, ultrasonic welding process and screen printing process. Through years of practice and exploration, accumulation Matching equipment system JET's products are made of medical-grade polymer materials polystyrene (GPPS), polypropylene (PP), and polyethylene (PE). They have environmental protection features such as light weight, temperature resistance, and pollution resistance. JET establishes a perfect quality management system and product inspection system in accordance with product technical standards and customer requirements. JET achieves refined management in the production process. Since the cost of domestic production factors is lower than that of developed countries, the cost of the company's products is lower than that of the same industry in developed countries. Compared with similar products of well-known foreign brands, JET's products are not inferior in performance indicators But the price has obvious advantages. JET's products are sold to more than 40 countries and regions including Europe and the United States, and it has entered the global supply chain system of an internationally renowned comprehensive laboratory supplies comprehensive service provider.

Company Overview

Full name Guangzhou Jet Biofiltration Co.,Ltd
Abbreviations Jet Biofiltration
Code 688026
Founded April 11, 2001
Listing January 22, 2020
Domicile Guangzhou
Website www.jetbiofil.com
Email jetzqb@jetbiofil.com
STAR Theme New Materials
CSRCSector Manufacturing
Has weighted voting rights structure? No

Financials

Highlights

  2019 2018 2017
Earnings Per Share 0.88 0.75 0.58
R&D expenditure as a % of operating revenue 5.08% 4.16% 4.71%
Operating Revenue 247.50 207.48 167.04
Net Income 66.15 52.83 40.36

Income Statement (Unit: RMB mn)

  2019 2018 2017
Operating Revenue 247.50 207.48 167.04
Operating Costs 136.85 115.79 91.10
Operating Income 76.44 61.17 43.48
Pretax Income 76.38 61.28 46.94
Income Tax 10.23 8.50 6.81
Net Income 66.15 52.83 40.36

Balance Sheet(Unit: RMB mn)

  2019 2018 2017
Assets
Current Assets-Total 219.29 189.53 106.03
Non-current Assets-Total 178.09 138.69 123.79
Total Assets 397.37 328.22 229.82
Liabilities
Current Liabilities-Total 42.24 38.68 34.99
Non-current Liabilities-Total 7.02 7.58 9.05
Total Liabilities 49.26 46.26 44.03
Stockholder's Equity
Share Capital 75.00 45.48 42.50
Retained Profits 171.29 111.83 75.63
Minority Interests     -0.13
Total Owners' Equity 348.11 281.96 185.79

Cash Flow Statement (Unit: RMB mn)

  2019 2018 2017
Net Cash Flows-Operating 61.02 45.12 46.67
Net Cash Flows-Investing -45.97 -72.16 -24.25
Net Cash Flows-Financing -2.39 39.48 -21.87

Top 10 Shareholders

Name No. of Shares Held (mn) % of Shares Held
袁建华(Yuan JiangHua) 31.00 31.00%
广州海汇财富创业投资企业(有限合伙) 13.72 13.72%
JET (H.K.) BIOSCIENCE CO.,LIMITED 12.53 12.53%
广东盛世润都股权投资管理有限公司-广东卓越润都创业投资合伙企业(有限合伙) 6.60 6.60%
广州市麦金顿投资管理合伙企业(有限合伙) 2.56 2.56%
李明智(Li MingZhi) 2.11 2.11%
广州萝岗区汇资投资管理合伙企业(有限合伙) 2.03 2.03%
共青城高禾中民投资管理合伙企业(有限合伙) 1.30 1.30%
珠海久银股权投资基金管理有限公司-宁波梅山保税港区久顺股权投资合伙企业(有限合伙) 1.12 1.12%
万联天泽资本投资有限公司-广州天泽瑞发股权投资中心(有限合伙) 0.87 0.87%
广州开发区广开知识产权运营投资中心(有限合伙) 0.87 0.87%
 

Legal Statement

All information contained herein is provided by the underlying company itself and is for informational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. The Shanghai Stock Exchange does not guarantee its accuracy and reliability and shall under no circumstance be responsible or liable for any error or for any loss directly or indirectly arising from any inaccuracy or omission or from any decision, action or non-action based on or in reliance upon the information herein.

Users may view and download the information herein for personal and non-commercial use free of charge subject to the laws of the People's Republic of China and the Legal Statement. No part of the information herein may be copied, downloaded, stored in a retrieval system or transmitted in any form or by any means, rented, displayed, performed, reproduced, photocopied, altered, sold, broadcast, published or otherwise in whole or in part in any manner for commercial purposes, without the prior written consent of the Shanghai Stock Exchange.

Users are hereby reminded that the Legal Statement represents your legally binding agreement with the Shanghai Stock Exchange. By accessing or using this website, you are also signifying your agreement with and acceptance of all the contents in the Legal Statement. The Shanghai Stock Exchange reserves the right to amend and interpret the Legal Statement.